HOPA By-Laws Amendment: Member Comment Period
After accepting recommendations from the Leadership Task Force and conducting a thorough legal review, the HOPA Board of Directors is proposing several By-Laws amendments and seeking member comment. Please review the proposed amendments, a crosswalk of the proposed amendments and the implementing resolution that would be needed to implement amendments to board terms.
HOPA responds to the CVS/Caremark’s decision to put public health above profits by ending sales of tobacco products in their stores with a letter to President and CEO Larry Merlo.
HOPA responded to the U.S. Department of Health and Human Services (HHS) in opposition of rescheduling hydrocodone combination products. Rescheduling of hydrocodone combination medicines would negatively impact appropriate management of pain and impact the patient’s quality of life. Read more.
Read the Scope of Hematology/Oncology Pharmacy Practice, a comprehensive document detailing its important role in patient care.
Make a Donation
Members and friends of HOPA can now make a donation to the HOPA Research Fund, supporting oncology pharmacy research and education. Donations to the HOPA Research Fund are tax deductible as permitted by law.